Anand Kiran Parikh insider trades

Open-market stock purchases and sales by Anand Kiran Parikh, President and CEO at Faeth Therapeutics, Inc, from SEC Form 4 filings since Feb 17, 2026.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +78%.

Recent trades

DateStockTradeValue
Jul 21, 2026FTH Faeth Therapeutics, IncBought (not open market)—
Jun 22, 2026FTH Faeth Therapeutics, IncBought$55.4K
Jun 22, 2026FTH Faeth Therapeutics, IncBought (not open market)—
Jun 22, 2026FTH Faeth Therapeutics, IncBought (not open market)—
Jun 15, 2026FTH Sensei Biotherapeutics, IncBought (not open market)—
Jun 15, 2026FTH Sensei Biotherapeutics, IncBought (not open market)—
Feb 19, 2026SNSE Sensei Biotherapeutics, IncBought (not open market)—
Feb 17, 2026FTH Sensei Biotherapeutics, IncBought (not open market)—
Feb 17, 2026SNSE Sensei Biotherapeutics, IncBought (not open market)—
Feb 17, 2026SNSE Sensei Biotherapeutics, IncBought (not open market)$107K
Feb 17, 2026SNSE Sensei Biotherapeutics, IncBought (not open market)$65.7K
Feb 17, 2026FTH Sensei Biotherapeutics, IncBought (not open market)$14.3K
Feb 17, 2026FTH Sensei Biotherapeutics, IncBought (not open market)$159K

Companies traded

  • FTH Faeth Therapeutics, Inc: 1 buy, last Jul 21, 2026
  • SNSE Sensei Biotherapeutics, Inc: other filings, last Feb 19, 2026

Get free alerts when Anand Kiran Parikh files a new trade →